C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2004
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	US20040229907 2-Aminoquinolinecarboxamides: neurokinin receptor ligands
11/18/2004	US20040229895 Tetracyclic benzamide derivatives and methods of use thereof
11/18/2004	US20040229893 Substituted benzothiazole amide derivatives
11/18/2004	US20040229889 HDAC inhibitor
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229863 Administering 4-amino-azepan-3-one compound for inhibiting cathepsin S
11/18/2004	US20040229862 Imidazo-benzothiazoles
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040228854 Novel chemical substance having morphogenetic and growth-accelerating activities
11/18/2004	CA2524397A1 Cannabinoid receptor ligands and uses thereof
11/18/2004	CA2524259A1 Imidazopyridine intermediates
11/18/2004	CA2523238A1 Amino-pyranoquinolines as serotonin reuptake inhibitors and 5-htia receptor agonists
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/17/2004	EP1476429A1 Novel pyridine- and quinoline-derivatives
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1289999B1 Antitumoral analogs of et-743
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004	EP0942732B1 Use of nk-1 receptor antagonists for treating movement disorders
11/17/2004	EP0942731B1 Use of nk-1 receptor antagonists for treating substance use disorders
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	CN1546473A Aliphatic amino substituted indole quinoline derivatives, their preparation method and pharmaceutical application
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004	CN1176087C High-performance camptothecin producing technology
11/16/2004	US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
11/16/2004	US6818664 Antitumor agent which comprises said compound or a physiologically acceptable salt thereof as an active ingredient.
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818649 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/16/2004	US6818641 Arthropodicidal carboxanilides
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096813A1 Heterocyclic compounds for use in the treatment of viral infections
11/11/2004	WO2004096805A2 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096139A2 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/11/2004	WO2004078875A3 Novel dyes and use thereof in imaging members and methods
11/11/2004	WO2004075853A9 Halogenated triptolide derivatives as immunomodulators and anticancer agents
11/11/2004	WO2004073598A3 Solid phase synthesis of antitumoral compounds
11/11/2004	WO2003097356A9 Camptothecin derivatives and polymeric conjugates thereof
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224945 Novel substituted pyrazole derivatives
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/11/2004	CA2523739A1 Heterocyclic compounds for use in the treatment of viral infections
11/11/2004	CA2523426A1 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/10/2004	EP1474690A1 E2 displacement assay for identifying inhibitors of hpv
11/10/2004	EP1474420A1 Quinazoline compounds
11/10/2004	EP1474411A2 Improved process for the production of dihydropyridines
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1545508A 1,2,4-trioxolane antimalarials
11/09/2004	US6815546 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
11/09/2004	US6815544 Coupling, acylation, treating with an allyl bromide, reduction, desilylation, cyclization and reduction
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/09/2004	CA2278139C Novel photochromic heterocyclic fused indenonaphthopyrans
11/04/2004	WO2004094367A2 A process for the stereoselective synthesis of lactones
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	WO2004093805A2 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004	WO2004093781A2 Podophyllotoxin derivatives as igf-1r inhibitors
11/04/2004	WO2004087145A3 Antibacterial agents
11/04/2004	WO2004078874A3 Novel dye complexes and use thereof in imaging members and methods
11/04/2004	WO2004069792A8 Quinoline-derived amide modulators of vanilloid vr1 receptor
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004	US20040220178 Substituted heterocycle fused gamma-carbolines
11/04/2004	CA2522946A1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/03/2004	EP1473288A1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases
11/03/2004	EP1472536A2 Broad spectrum inhibitors
11/03/2004	EP1472223A1 Gamma secretase inhibitors
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1392697B1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f]quinoline
11/03/2004	EP1255759A4 Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/02/2004	US6812345 Fused pyridine-benzazapine, benzoxepin, or benzothiepin derivatives; hypocholesterolemic and hypolipidemic agents
11/02/2004	US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004	CA2301787C New derivatives of benzo[3,4]cyclobuta[1,2-c]pyrrole, the procedure for preparing them and the pharmaceutical compounds that contain them
11/02/2004	CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors
11/02/2004	CA2282279C Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
11/02/2004	CA2103454C Macrocyclic immunomodulators
10/2004
10/28/2004	WO2004092203A2 Process for preparing macrocyclic compounds
10/28/2004	WO2004092179A1 Spiro derivative, production process, and antioxidant
10/28/2004	WO2004092178A1 Benzoxepino-11-piperidylidene compounds and process for production thereof
10/28/2004	WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004091504A2 Substituted quinobenzoxazine analogs
10/28/2004	WO2004078479A3 Imaging system
10/28/2004	WO2004078030A3 Rhodol derivatives useful as image dyes
10/28/2004	WO2004075823A8 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
10/28/2004	US20040215015 Sulfonated derivatives of perylenetetracarboxylic acid dibenzimidazole sulfoderivatives anisotropic films for liquid crystals
10/28/2004	US20040214871 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester
10/28/2004	US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS
10/28/2004	US20040214852 Polysubstituted imidazopyridines
10/28/2004	US20040214849 via injection or intravenous drip
10/28/2004	US20040214815 Therapeutic compounds
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug

1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 298